Major Growth Driver Identified in 2025 Neuroscience Antibodies & Assays Market: Surge In Neurological Illnesses Spurs Remarkable Growth In The Neuroscience Antibodies & Assays Market

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Neuroscience Antibodies & Assays Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for neuroscience antibodies and assays has experienced significant growth in the recent past. It is projected to expand from $4.52 billion in 2024 to $5.07 billion in 2025, yielding a compound annual growth rate (CAGR) of 12.2%. The increase during the historic period can be credited to factors such as research funding, advancements in drug discovery and development, surge in neurodegenerative diseases, government policy support, and the evolution of personalized medicine.

Neuroscience Antibodies & Assays Market Size Forecast: What's the Projected Valuation by 2029?
The market size of neuroscience antibodies & assays is predicted to experience swift expansion in the coming years. The market will surge to $8.74 billion by 2029 with a CAGR of 14.6%. This projected growth during the forecast period can be ascribed to factors such as partnerships, neurology telemedicine, educational and training advancements, biomarker-based therapies, and a focus on neuroimmunology. Noteworthy trend forecasts for the period include assays for microrna and non-coding rna, digital pathology, assays compatible with advanced imaging, single-cell analysis, and 3D organoid models.

View the full report here:
https://www.thebusinessresearchcompany.com/report/neuroscience-antibodies-and-assays-global-market-report

What Are the Drivers Transforming the Neuroscience Antibodies & Assays Market?
A global surge in neurological diseases is predicted to drive the growth of the neuroscience antibodies & assays market. These illnesses, affecting the nervous system, include conditions such as dementia, epilepsy, Alzheimer's disease, among others. As their incidence increases, it necessitates further research and development for their treatment. This is where antibodies and assays come in; they are essential for R&D activities, helping to study the development, structure, systems, functions, disorders, and degeneration of the nervous system. As such, the rise in neurological illness results in the growth of the neuroscience antibodies & assays market. In illustration, a report by the US-based federal agency, Centers for Disease Control and Prevention, revealed about 2.9 million US adults (18 and older) had active epilepsy in the years 2021-2022. Furthermore, the Alzheimer's Association (a US non-profit organization) stated that around 6.5 million people in the US were diagnosed with Alzheimer's disease, as per 2022 data. Therefore, this increased occurrence of neurological diseases worldwide is fueling the advancement of the neuroscience antibodies and assays market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7548&type=smp

What Long-Term Trends Will Define the Future of the Neuroscience Antibodies & Assays Market?
The rise in technological developments is a prominent trend emerging in the neuroscience antibodies and assays market. Leading firms in the sector are incorporating fresh technologies, including the NeuroNexus Summa Framework technology, in a bid to maintain their market standing. For example, NeuroNexus Technologies, an American company specializing in inventive neural interface products and technologies, revealed in February 2022 the unveiling of the NeuroNexus Summa Framework. This solution was crafted for experienced electrophysiologists and life science researchers seeking to seamlessly integrate electrical signal read-outs from biological cells and tissues into their research methodology.

Which Segments in the Neuroscience Antibodies & Assays Market Offer the Most Profit Potential?
The neuroscience antibodies & assays market covered in this report is segmented -

1) By Product: Consumables, Instruments
2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies
3) By Application: In Vitro Diagnostics, Research, Drug Discovery
4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies

Subsegments:
1) By Consumables: Antibodies, Assay Kits, Assay Kits
2) By Instruments: Spectrophotometers, Microplate Readers, Flow Cytometers, Western Blotting Systems, Imaging Systems, Automated Workstations

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7548&type=smp

Which Firms Dominate the Neuroscience Antibodies & Assays Market by Market Share and Revenue in 2025?
Major companies operating in the neuroscience antibodies & assays market include Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc., R&D Systems Inc., RayBiotech Inc., StressMarq Biosciences Inc., Synaptic Systems GmbH, Tocris Bioscience, Alomone Labs Ltd., AnaSpec Inc., Antibodies.com, Antibody Solutions, Arbor Assays, Uscn Life Science Inc., Zymo Research Corp., AAT Bioquest Inc., Abbexa Ltd., ACROBiosystems Inc., Active Motif Inc., AdipoGen Life Sciences, Advanced Targeting Systems Inc., AgriSera AB

Which Regions Offer the Highest Growth Potential in the Neuroscience Antibodies & Assays Market?
North America was the largest region in the neuroscience antibodies & assays market in 2024. The regions covered in the neuroscience antibodies & assays market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7548

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.